17 September 2021 · This guidance for Chief Pharmacists supports the pharmacy institutional readiness for the management of casirivimab and imdevimab in COVID-19 infection.
17 September 2021 · Initial supplies of casirivimab and imdevimab will be pandemic packs supplied under a Batch Specific Variation to the conditional marketing authorisation